Inflammatory bowel disease is accompanied by a number of changes in the intestines, such as a change in epithelial permeability, a change in the composition of […]
In work presented at the 2022 EULAR Congress, Dr. Jens Kristian Pedersen and colleagues used data from the DANBIO registry to describe the all-cause mortality risk […]
The risk of acquiring COVID-19—and the severity of illness—in the context of immune-mediated inflammatory diseases (IMIDs) and their therapy, remains incompletely understood. Reported infection rates and […]
Nearly 43% of patients with non-small cell lung cancer (NSCLC) whose lung cancers harbored a specific KRAS mutation responded to the experimental drug adagrasib, and the […]